June 12, 2026
India's obesity drug market expected to exceed $1 billion in two years, analyst says
A more than 35 percent rally in the company's stock this year has largely been driven by the explosive growth of the weight-loss drug market
Orforglipron improves cardiovascular risk factors, and reduces inflammation marker by 47.7 percent
Shares of the drugmaker have climbed nearly 4 percent to $722 during early trading
